261 related articles for article (PubMed ID: 15569818)
1. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
Chen HC; Farese RV
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
[TBL] [Abstract][Full Text] [Related]
2. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.
Smith SJ; Cases S; Jensen DR; Chen HC; Sande E; Tow B; Sanan DA; Raber J; Eckel RH; Farese RV
Nat Genet; 2000 May; 25(1):87-90. PubMed ID: 10802663
[TBL] [Abstract][Full Text] [Related]
3. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
[TBL] [Abstract][Full Text] [Related]
4. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
[TBL] [Abstract][Full Text] [Related]
5. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1.
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV
J Clin Invest; 2002 Apr; 109(8):1049-55. PubMed ID: 11956242
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue.
Chen HC; Stone SJ; Zhou P; Buhman KK; Farese RV
Diabetes; 2002 Nov; 51(11):3189-95. PubMed ID: 12401709
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
8. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
Choi SS; Diehl AM
Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
[TBL] [Abstract][Full Text] [Related]
9. Enhancing energy and glucose metabolism by disrupting triglyceride synthesis: Lessons from mice lacking DGAT1.
Chen HC
Nutr Metab (Lond); 2006 Jan; 3():10. PubMed ID: 16448557
[TBL] [Abstract][Full Text] [Related]
10. Obesity resistance and enhanced glucose metabolism in mice transplanted with white adipose tissue lacking acyl CoA:diacylglycerol acyltransferase 1.
Chen HC; Jensen DR; Myers HM; Eckel RH; Farese RV
J Clin Invest; 2003 Jun; 111(11):1715-22. PubMed ID: 12782674
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of acyl coenzyme a:diacylglycerol acyltransferase 1 increases leptin sensitivity in murine obesity models.
Chen HC; Ladha Z; Farese RV
Endocrinology; 2002 Aug; 143(8):2893-8. PubMed ID: 12130553
[TBL] [Abstract][Full Text] [Related]
12. DGAT inhibitors for obesity.
Matsuda D; Tomoda H
Curr Opin Investig Drugs; 2007 Oct; 8(10):836-41. PubMed ID: 17907060
[TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease: emerging mechanisms and consequences.
Turkish AR
Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):128-33. PubMed ID: 18301087
[TBL] [Abstract][Full Text] [Related]
15. Diacylglycerol acyltransferases: Potential roles as pharmacological targets.
Zammit VA; Buckett LK; Turnbull AV; Wure H; Proven A
Pharmacol Ther; 2008 Jun; 118(3):295-302. PubMed ID: 18508126
[TBL] [Abstract][Full Text] [Related]
16. Expression of DGAT2 in white adipose tissue is regulated by central leptin action.
Suzuki R; Tobe K; Aoyama M; Sakamoto K; Ohsugi M; Kamei N; Nemoto S; Inoue A; Ito Y; Uchida S; Hara K; Yamauchi T; Kubota N; Terauchi Y; Kadowaki T
J Biol Chem; 2005 Feb; 280(5):3331-7. PubMed ID: 15550388
[TBL] [Abstract][Full Text] [Related]
17. On the biogenesis of lipid bodies in ancient eukaryotes: synthesis of triacylglycerols by a Toxoplasma DGAT1-related enzyme.
Quittnat F; Nishikawa Y; Stedman TT; Voelker DR; Choi JY; Zahn MM; Murphy RC; Barkley RM; Pypaert M; Joiner KA; Coppens I
Mol Biochem Parasitol; 2004 Nov; 138(1):107-22. PubMed ID: 15500922
[TBL] [Abstract][Full Text] [Related]
18. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
19. Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion.
Okawa M; Fujii K; Ohbuchi K; Okumoto M; Aragane K; Sato H; Tamai Y; Seo T; Itoh Y; Yoshimoto R
Biochem Biophys Res Commun; 2009 Dec; 390(3):377-81. PubMed ID: 19732742
[TBL] [Abstract][Full Text] [Related]
20. Sesquiterpenoids isolated from the flower buds of Tussilago farfara L. inhibit diacylglycerol acyltransferase.
Park HR; Yoo MY; Seo JH; Kim IS; Kim NY; Kang JY; Cui L; Lee CS; Lee CH; Lee HS
J Agric Food Chem; 2008 Nov; 56(22):10493-7. PubMed ID: 18937486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
